Barriers to the diagnosis and treatment of venous thromboembolism in advanced cancer patients: A qualitative study
- 23 October 2012
- journal article
- research article
- Published by SAGE Publications in Palliative Medicine
- Vol. 27 (4), 339-348
- https://doi.org/10.1177/0269216312461678
Abstract
Background: Venous thromboembolism is common in patients with cancer and the risk increases with advanced disease. Evidence-based treatment is administration of low-molecular-weight heparin daily by subcutaneous injection. Clinical uncertainty exists as to whether treating venous thromboembolism in advanced disease is in the patient’s best interests. Aim: To explore the barriers faced by doctors when diagnosing and treating patients with cancer-associated thrombosis. Design: Qualitative, in-depth interview study using framework analysis. Participants: Forty-five UK doctors across urban and rural settings, from three specialties, oncology, palliative medicine and general practice, with a mixture of senior and junior staff. Results: Organisational constraints served to act as barriers to the diagnosis and treatment of this patient group. Issues were identified around access to diagnostic testing. A cancer-associated thrombosis patient having to wait for a scan as an inpatient was sometimes deemed unnecessary. Patient ambulance transport (especially transportation of hospice patients) was often viewed as inflexible and bureaucratic. Low-molecular-weight heparin prescribing had sometimes led to tension between the acute, community and hospice sectors about whose prescribing responsibility this was, with different areas having divergent ‘rules’ and practices. Finally, the doctors interviewed discussed the role of nurses. Conclusions: Multiple logistical barriers are hindering best patient care for people with cancer-associated thrombosis. There is scope for some of these barriers to be reduced to improve service delivery and ultimately patient care. The research team proposes practical recommendations, which could yield direct benefit for patients and the health services.This publication has 26 references indexed in Scilit:
- Diagnosis and management of people with venous thromboembolism and advanced cancer: how do doctors decide? a qualitative studyBMC Medical Informatics and Decision Making, 2012
- Antithrombotic Therapy for VTE Disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2012
- Long-term therapy with low-molecular-weight heparin in cancer patients with venous thromboembolismThrombosis and Haemostasis, 2012
- Epidemiology and pathophysiology of cancer-associated thrombosisBritish Journal of Cancer, 2010
- Review Article: Role of Palliative Low-Molecular-Weight Heparin for Treating Venous Thromboembolism in Patients With Advanced CancerAmerican Journal of Hospice and Palliative Medicine®, 2010
- Venous thromboembolism in patients with advanced cancer under palliative care: additional risk factors, primary/secondary prophylaxis and complications observed under normal clinical practicePalliative Medicine, 2008
- Factors influencing hospice thromboprophylaxis policy: a qualitative studyPalliative Medicine, 2008
- The challenges of managing cancer related venous thromboembolism in the palliative care settingPublished by Oxford University Press (OUP) ,2007
- Have Palliative Care Teams' Attitudes Toward Venous Thromboembolism Changed? A Survey of Thromboprophylaxis Practice Across British Specialist Palliative Care Units in the Years 2000 and 2005Journal of Pain and Symptom Management, 2006
- Venous Thrombosis in Cancer Patients: Insights from the FRONTLINE SurveyThe Oncologist, 2003